619 related articles for article (PubMed ID: 24667368)
1. Protocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged AβPP/PS1 double transgenic mice.
Song Y; Cui T; Xie N; Zhang X; Qian Z; Liu J
Int Immunopharmacol; 2014 May; 20(1):276-81. PubMed ID: 24667368
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg5 improves cognitive dysfunction and beta-amyloid deposition in STZ-induced memory impaired rats via attenuating neuroinflammatory responses.
Chu S; Gu J; Feng L; Liu J; Zhang M; Jia X; Liu M; Yao D
Int Immunopharmacol; 2014 Apr; 19(2):317-26. PubMed ID: 24503167
[TBL] [Abstract][Full Text] [Related]
3. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
4. Osthole Upregulates BDNF to Enhance Adult Hippocampal Neurogenesis in APP/PS1 Transgenic Mice.
Liu H; Xue X; Shi H; Qi L; Gong D
Biol Pharm Bull; 2015; 38(10):1439-49. PubMed ID: 26424009
[TBL] [Abstract][Full Text] [Related]
5. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
[TBL] [Abstract][Full Text] [Related]
6. Gender difference in valproic acid-induced neuroprotective effects on APP/PS1 double transgenic mice modeling Alzheimer's disease.
Long Z; Zeng Q; Wang K; Sharma A; He G
Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):930-938. PubMed ID: 27614317
[TBL] [Abstract][Full Text] [Related]
7. Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation.
Guo HB; Cheng YF; Wu JG; Wang CM; Wang HT; Zhang C; Qiu ZK; Xu JP
Neuroscience; 2015 Apr; 290():530-42. PubMed ID: 25662507
[TBL] [Abstract][Full Text] [Related]
8. Geniposidic acid ameliorates spatial learning and memory deficits and alleviates neuroinflammation via inhibiting HMGB-1 and downregulating TLR4/2 signaling pathway in APP/PS1 mice.
Zhou Z; Hou J; Mo Y; Ren M; Yang G; Qu Z; Hu Y
Eur J Pharmacol; 2020 Feb; 869():172857. PubMed ID: 31837991
[TBL] [Abstract][Full Text] [Related]
9. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
10. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
11. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
Yang H; Yang H; Xie Z; Wang P; Bi J
Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263
[TBL] [Abstract][Full Text] [Related]
12. A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model.
Wei L; Yang H; Xie Z; Yang S; Yang H; Zhao C; Wang P; Xu S; Miao J; Zhao B; Bi J
J Alzheimers Dis; 2012; 30(3):531-43. PubMed ID: 22451314
[TBL] [Abstract][Full Text] [Related]
13. Electroacupuncture decreases cognitive impairment and promotes neurogenesis in the APP/PS1 transgenic mice.
Li X; Guo F; Zhang Q; Huo T; Liu L; Wei H; Xiong L; Wang Q
BMC Complement Altern Med; 2014 Jan; 14():37. PubMed ID: 24447795
[TBL] [Abstract][Full Text] [Related]
14. Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation.
Gallagher JJ; Minogue AM; Lynch MA
Neurodegener Dis; 2013; 11(1):33-41. PubMed ID: 22627185
[TBL] [Abstract][Full Text] [Related]
15. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
16. Tauroursodeoxycholic acid suppresses amyloid β-induced synaptic toxicity in vitro and in APP/PS1 mice.
Ramalho RM; Nunes AF; Dias RB; Amaral JD; Lo AC; D'Hooge R; Sebastião AM; Rodrigues CM
Neurobiol Aging; 2013 Feb; 34(2):551-61. PubMed ID: 22621777
[TBL] [Abstract][Full Text] [Related]
17. Icariin, a phosphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling.
Jin F; Gong QH; Xu YS; Wang LN; Jin H; Li F; Li LS; Ma YM; Shi JS
Int J Neuropsychopharmacol; 2014 Jun; 17(6):871-81. PubMed ID: 24513083
[TBL] [Abstract][Full Text] [Related]
18. Memantine improves spatial learning and memory impairments by regulating NGF signaling in APP/PS1 transgenic mice.
Liu MY; Wang S; Yao WF; Zhang ZJ; Zhong X; Sha L; He M; Zheng ZH; Wei MJ
Neuroscience; 2014 Jul; 273():141-51. PubMed ID: 24846616
[TBL] [Abstract][Full Text] [Related]
19. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
20. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]